REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary
Home > Formulary : Paediatric > Recent Decisions > 2024 >

Decisions 3rd September 2024

Decisions 3rd September 2024

New Drug Requests

Botulinum toxin A (Botox) for the treatment of functional symptoms of facial palsy (TLS Red)

 

Shared Care Protocols

Aripiprazole shared care protocol updated

 

Melatonin - Following on from the December 2022 JFG meeting: 
For both adult and paediatric patients, the Formulary now covers the prescribing of melatonin for intrinsic sleep disorder with one of:

    • Autism Spectrum Disorder (ASD) diagnosis,
    • Learning Disability (LD) diagnosis,
    • a neurodevelopmental disorder / disability (e.g. cerebral palsy) (excluding those with Attention Deficit Hyperactivity Disorder as a standalone diagnosis)
    • or REM sleep disorder
      Further information is available in the updated shared care protocol, available on both the adult and paediatric formulary pages. Clinicians should familiarise themselves with this document which provides information on formulations and many other common prescribing issues.